Public hearing on separated product and manufacturing business licence

Published: 2006-01-18 06:56:00

Updated: 2006-01-18 06:56:00

A public hearing on the subject of "Revised pharmaceutical affairs act covering the separated product and business licence" was scheduled to hold at the auditorium of the National Assembly Representative's House at 2:00 to 5:00 p.m. on Jan. 17 (Tue).

The Korea Pharmaceutical Manufacturers Association (KPMA) called for the pharmaceutical communities to take part in the public hearing so that...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.